World Bank Makes Progress in Promoting Medical Reform in China

The newspaper reporter Pan Xi recently, the World Bank released a series of "China's medical reform policy recommendations" completed in cooperation with the Chinese government. The report looks at the lessons learned from China's ongoing health care system reform. The five policy recommendations contained in the report review and analyze the reform process and evaluate the preliminary results.

Each policy construction report focuses on different key areas. These areas are related to the success of medical reform. The report proposes opinions on how to refine and improve medical reform in the process of gradual progress in the next 5 to 10 years.

Lu Genbo, head of the Human Development Department of the World Bank China, said: “This series of reports is intended to provide policy makers and practical workers with reference to the implementation of new medical reform measures announced by the government and introduces best practices in China and other countries in the world. ."

China's Public Reform Reform Overview Since the public reforms in China in the mid-1980s, there have been increases in the number of services and services, but at the same time there has also been a rise in the public enthusiasm for high-paying, high-profit services. The project realized income generation, ** blind expansion in infrastructure construction and the purchase of advanced medical equipment, uneven distribution of medical resources, and over-opening of drugs, resulting in decreased patient satisfaction.

The “Review of Reforms in China's Public Sectors” describes the practices adopted by some other countries to implement reforms, including successful and less successful cases.

However, China is a big country and the situation is rather complicated. There is no standard model applicable to hospitals at all levels. It is necessary to provide reasonable and scientifically based medical services according to China’s actual conditions and train a high-quality hospital management backbone team. And establish the information systems needed for policy planning, performance monitoring, accountability and evaluation.

China's medical service provider payment system reform: revelation of international experience The report analyzes emerging supplier payment systems such as case-based payment and performance-based payment and their respective limitations. Although the reforms have already started, they are not perfect. For example, service providers are paying too much attention to those services that have performance evaluations, and those services that are not linked to payment are ignored.

In light of the above, the report suggests that China must monitor carefully when implementing payments. Therefore, China must use the new payment model to reform the current dispersal-oriented medical service delivery system.

Generic Drug Policy: The cornerstone of China's basic drug policy Drug costs 40% of the country's total medical expenditure, compared with most countries, this ratio is quite high. The use or overuse of drugs is neither efficient nor effective from the perspective of economy.

The "Generic Drug Policy - The Cornerstone of China's Essential Drug Policy" report believes that the main problem lies in the supplier payment system. Under this system, ** and doctors rely on drug sales to obtain additional income.

The report pointed out that to reform this system, it needs to use other sources of funds instead of pharmaceutical sales revenue. For example, through direct subsidies, increasing user fees, or increasing insurance payments for medical services.

In addition to decoupling drug sales from medical staff income, measures need to be taken to apply strict quality standards to generic drugs, change the notion that doctors and patients think that “generic drugs are inferior to brand drugs,” and establish incentive mechanisms to promote the use of generic drugs.

The road to reforms in drug financing, pricing and use in China This report examines the issues of drug financing, pricing and use in China, and the development of the drug system.

China had become the ninth largest pharmaceutical market in the world in 2004, and drug sales grew at an average annual rate of 28% in the first few years of this century. The report proposes a series of measures to promote and deepen the reform, including further reform of the national essential medicine system, expansion of generic drug production and promotion of the use of generic drugs, improvement of drug pricing, implementation of zero-rate policy on drugs, and making the open procurement system more fair. , equality and transparency, as well as learning advanced international experience.

China's Path to a Comprehensive System of Social Security The current system of China's social security system is a mixture of separate systems targeting the employed and unemployed, and the urban and rural populations. Employer units and employee contributions, personal contributions, and government subsidies are the main source of funds for these different systems. The level of protection and benefits also varies depending on the level of funding.

The report explores the reform options and proposals that China is facing to meet the basic needs of all people. The report emphasizes the need to achieve greater levels of fairness among different existing **, with special focus on low-income groups and migrant workers; a gradual approach should be adopted to provide uniform basic welfare for all individuals and families; Basic unit medical insurance system.

The report also pointed out that it is necessary to coordinate the large number of independent operations across the country, and establish a provincial-level system.